Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17.4Revenue $M0.2Net Margin (%)-24,256.1Altman Z-Score-6.4
Enterprise Value $M-17.8EPS $-0.4Operating Margin %-42,559.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score56.6Pre-tax Margin (%)-24,726.7Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsN
Price/Sales9745-y EBITDA Growth Rate %-24.6Current Ratio4.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-159.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M95.9ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEZSFirst Eagle Investment 2010-03-31 Sold Out $4.74 - $5.58
($4.99)
$ 0.18-96%Sold Out0
AEZSFirst Eagle Investment 2009-12-31 Reduce$4.734 - $7.5
($6.09)
$ 0.18-97%Reduce 91.09%20,753
AEZSFirst Eagle Investment 2009-09-30 Buy 0.02%$5.34 - $16.98
($9.66)
$ 0.18-98%New holding232,983
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JrgenDirector 2014-11-12Buy60,000$0.6-70 view
Ernst, JrgenDirector 2014-11-12Buy39,400$0.62-70.97 view
Ernst, JrgenDirector 2014-11-12Buy7,600$0.61-70.49 view
Ernst, JrgenDirector 2014-11-12Buy3,100$0.61-70.49 view
Ernst, JrgenDirector 2014-11-12Buy14,900$0.61-70.49 view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy8,500$0.57-68.42 view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy1,000$0.57-68.42 view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy34,437$0.57-68.42 view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy3,000$0.58-68.97 view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy128,063$0.58-68.97 view

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    siva Jun 29 2015 
    siva Jun 29 2015 
    siva Jun 29 2015 
    siva Jun 29 2015 
    siva Jun 29 2015 
    Siva Jun 27 2015 
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    comment on AEZS Oct 26 2011 

    More From Other Websites
    August 4, 2015 Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth... Aug 04 2015
    Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in... Aug 04 2015
    Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in... Aug 04 2015
    July 29, 2015 Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development Jul 29 2015
    Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development Jul 29 2015
    Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development Jul 29 2015
    July 28, 2015 Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer... Jul 28 2015
    Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology Jul 28 2015
    Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology Jul 28 2015
    July 27, 2015 Aeterna Zentaris Commences Promotional Activities for EMD Serono’s Saizen® Jul 27 2015
    Aeterna Zentaris Commences Promotional Activities for EMD Serono's Saizen® Jul 27 2015
    Aeterna Zentaris Commences Promotional Activities for EMD Serono's Saizen® Jul 27 2015
    The Biotech Rocket is Running Out of Fuel: Three Stocks to Keep You Soaring - Broad Street Alerts Jul 23 2015
    Aeterna Zentaris' Endometrial Cancer Study Fully Enrolled - Analyst Blog Jul 01 2015
    Ergomed’s Co-Development Partner Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3... Jun 30 2015
    June 30, 2015 Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3 Study with... Jun 30 2015
    Co-development partner news Jun 30 2015
    Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3 Study with Zoptarelin Doxorubicin... Jun 30 2015
    Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3 Study with Zoptarelin Doxorubicin... Jun 30 2015
    June 25, 2015 Aeterna Zentaris Announces Selection of Ergomed to Conduct Confirmatory Phase 3... Jun 25 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK